Presence of Lobular Carcinoma In Situ Does Not Increase Local Recurrence in Patients Treated with Breast-Conserving Therapy |
| |
Authors: | Robin M Ciocca Tianyu Li Gary M Freedman Monica Morrow |
| |
Institution: | (1) Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA;(2) Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, PA, USA;(3) Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA;(4) Breast Surgery Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA |
| |
Abstract: | Background Lobular carcinoma in situ (LCIS) is known to be a risk factor for the development of invasive breast cancer. Debate continues
as to whether LCIS is also a precursor lesion. We hypothesized that, if LCIS were a precursor, its presence in the lumpectomy
specimen, particularly at the margin, could increase local recurrence (LR) after breast-conserving therapy (BCT).
Methods 2894 patients treated with BCT for ductal carcinoma in situ (DCIS), stage I or II breast cancer between 1/80 and 5/07 were
identified. Patients with DCIS or invasive cancer at the margins or those receiving neoadjuvant therapy were excluded. Group
A had 290 patients with LCIS in the lumpectomy; 84 had LCIS at the final margin. Group B included 2604 patients with no evidence
of LCIS.
Results Median patient age in group A and B was 57 and 58 years, respectively (P = 0.05); 12% and 13%, respectively, of patients in group A and B had margins <2 mm (P = NS). The histologic distribution of tumor types in group A was lobular in 47.2%, ductal in 34.5%, DCIS in 11.4%, and other
invasive histologies in 6.9%, compared with 4.1%, 76.3%,13.6%, and 6.0% for group B, respectively (P < 0.0001). There was no significant difference between the groups in tumor–node–metastasis (TNM) stage. The crude rate of
LR was 4.5% in group A and 3.8% in group B (P = NS). Five- and 10-year actuarial LR rates for LCIS at the margin were 6% and 6%, 1% and 15% for LCIS present but not at
the margin, and 2% and 6% for no LCIS (P = NS), for group A and B, respectively. In multivariate analysis, menopausal status and adjuvant therapy use were significant
predictors of LR. LCIS, either in the specimen or at the margin, was not significantly associated with LR.
Conclusion Presence of LCIS, even at the margin, in BCT specimens does not have an impact on LR. Re-excision is not indicated if LCIS
is present or close to margin surfaces. These findings do not support consideration of LCIS as a precursor to the development
of invasive lesions.
Abstract presentation at the Scientific Session of the 61st Annual Cancer Symposiumof the Society of Surgical Oncology, Chicago,
IL, March 13–16, 2008. |
| |
Keywords: | Breast cancer Lobular carcinoma in situ Breast-conserving therapy Local recurrence |
本文献已被 PubMed SpringerLink 等数据库收录! |
|